Also trades as: LCTX.TA (TLV) · $vol 0M
LCTX AMEX
Lineage Cell Therapeutics, Inc.
1W: -9.8%
1M: -16.3%
3M: -30.1%
YTD: -43.4%
1Y: -45.0%
3Y: -21.9%
5Y: -63.9%
$0.93
+0.03 (+2.89%)
Weekly Expected Move ±9.0%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$13M
Revenue
+19.9% YoY
$-32M
Net Income
+21.1% YoY
$-24M
Free Cash Flow
-4.3% YoY
82.5%
Gross Margin
-834.7%
Op. Margin
138.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-59.0%
ROA-32.7%
ROIC-171.3%
Valuation
P/E-6.6
P/B3.8
EV/EBITDA-8.0
Leverage
Debt/Equity0.04
Current Ratio6.61
Interest Cov.0.0x
Quality Scores
Piotroski F5/9
Altman Z-2.30
Beneish M2.83